SOUTH WINDSOR, Conn., April 11, 2018 -- Oxford Performance Materials, Inc. (OPM), a leader in advanced materials science and high performance additive manufacturing (HPAM™), today announced the launch of OXPEKK®-SC (Solution Casting).
OXPEKK-SC is a proprietary material developed by OPM for creating water-based solution castable PEKK into ultra-thin films. When formed, the films have the full mechanical, thermal and electrical properties of PEKK.
OPM has been developing poly-ether-ketone-ketone (PEKK) process and application technologies exclusively since its founding in 2000. Target applications for the patent pending OXPEKK-SC film forming technology include sizing on fibers such as glass and carbon, insulating coatings on conductors, wear coating on metallic substrates, and a wide range of chemical resistant coatings. The coating can be applied on any substrate that is not adversely affected by a thermal process cycle of 340◦C. The OXPEKK-SC film tenaciously bonds to most substrates - including metallic, glass, carbon, ceramic & carbon - and can be spray applied or dipped with a minimum thickness of 100nm.
“PAEK polymers have long been applied as coating to various substrates. However, the market has long desired a water-based solution casting technology that involves simple processing but delivers ultra-thin films,” said Scott DeFelice, CEO of Oxford Performance Materials. “OXPEKK-SC meets this challenge head-on, and has been in development with key OPM development partners for some time. The product is now ready for immediate introduction into the broader market.”
DeFelice continued, “Our initial focus had been to use this technology as functionalizing and process aid for fibers, however we see substantial opportunities in the energy sector, chemical process industries and semiconductor sectors.”
About Oxford Performance Materials, Inc.
A recognized leader in advanced materials science, Oxford Performance Materials Inc. (OPM) was founded in 2000 to exploit and commercialize the world’s highest performing thermoplastics, with a focus on poly-ether-ketone-ketone (PEKK). OPM develops proprietary material, process, and application technologies and applies high performance additive manufacturing (HPAM™) to produce fully functional, end-use structural parts. OPM Biomedical is a pioneer in personalized medicine, 3D printing OsteoFab® cranial and facial implants as an OEM, and spinal implants and additional products on a contract manufacturing basis. OPM Biomedical is the first and only company to receive FDA 510(k) clearance to manufacture 3D printed patient-specific polymeric implants, and has a total of four 510(k) clearances in its portfolio. The OPM Materials business unit develops proprietary OXPEKK® thermoplastic products and other materials for biomedical, aerospace, defense, and industrial applications. For more information, please visit: www.oxfordpm.com
Company Contact:
Bernie Plishtin
Oxford Performance Materials
860-656-9446
[email protected]
Media Contact:
Cory Ziskind
ICR
646-277-1232
[email protected]


ANZ Shares Hit Record High After Strong Q1 Profit and Cost-Cutting Gains
xAI Co-Founder Jimmy Ba Departs as Elon Musk’s AI Startup Faces Turbulence
Ralph Lauren Unveils Elegant Fall 2026 Women’s Collection Ahead of New York Fashion Week
Cloudflare Forecasts Strong Revenue Growth as AI Fuels Cloud Services Demand
Russia Signals Further Restrictions on Telegram Amid Ongoing Regulatory Disputes
Russia Moves to Fully Block WhatsApp as Kremlin Pushes State-Backed MAX App
U.S. Judge Allows Jeffrey Epstein Sex Trafficking Lawsuit Against Bank of America to Proceed
How Marco Pharma International Preserves German Homeopathic Traditions in America
Ancora Holdings Builds $200M Stake in Warner Bros Discovery, Targets Netflix Asset Sale Plan
Standard Chartered Names Peter Burrill as Interim Group CFO Following Diego De Giorgi’s Exit
AST SpaceMobile Joins MSCI ACWI Index as Largest New Addition, Boosting Market Visibility
Boeing Reports Major Supply Chain Quality Improvements After Spirit AeroSystems Deal
U.S. Commerce Department Reaches $252 Million Settlement With Applied Materials Over China Exports
SMIC Shares Slide Despite Strong AI-Driven Earnings as Margin Pressure Looms
AbbVie Sues HHS Over Medicare Price Controls on Botox Under Inflation Reduction Act
FAA Confirms $1.5 Billion Peraton Contract as U.S. Air Traffic Control Overhaul Accelerates
Spirit Airlines Seeks Court Approval to Auction 20 Airbus A320/A321 Aircraft Amid Bankruptcy 



